Allergan to Buy MAP Pharmaceuticals for $958M

REPLAY VIDEO
Your next video will start in
Pause
  • Info

  • Comments

Jan. 22 (Bloomberg) -- Allergan agreed to pay $25 per share for MAP Pharmaceuticals in what the companies called a “definitive merger agreement.” Matt Miller reports on Bloomberg Television's "Bloomberg Rewind." (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change